Biotrend

STAT3 (Signal Transducer and Activator of Transcription 3), activated (pY704)

#STAT3-9E12 · western blot

3
Citing papers
377
Combined citations
Supplier page Find this product

Research areas

Cancer-related Molecular Pathways1Cutaneous lymphoproliferative disorders research1Cytokine Signaling Pathways and Interactions1Epigenetics and DNA Methylation1Fibroblast Growth Factor Research1Lymphoma Diagnosis and Treatment1T-cell and Retrovirus Studies1TGF-β signaling in diseases1

Papers citing this product

1
Activated signal transducer and activator of transcription 3 (STAT3) supports the malignant phenotype of human pancreatic cancer
Gastroenterology·2003·255 cit.·DOI
2
Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma
Oncotarget·2015·83 cit.·DOI
3
Activating Somatic FGFR2 Mutations in Breast Cancer
PLoS ONE·2013·39 cit.·DOI

Also available from other vendors

This target has 207 citing papers across all vendors combined

VendorProductPricePapers
DSHBSignal transducer and activator of transcription 2 antibody - Protein Capture Reagents Program, produced by JHU/CDI; National Institutes of Health—200
D.R. Hyde, University of Notre Dame; Indiana; USAanti-Stat3 (Ab3-Stat3)——
Hyde labStat3—4
STAT3 (Signal Transducer and Activator of Transcription 3), activated (pY704) — Evidence — PubIndex